What is a pharmacy "White" list and what will it mean for patients?

A key part of the Falsified Medicines Directive (FMD) will be the need for Member States to produce a list of pharmacies, called the "White" list, that have been approved by the national regulatory body.

Essentially this means that medicines MUST be offered for sale via the internet to the public. 

The Member States therefore have a legal obligation to have procedures in place that ensure those licensing of entities  are capable and qualified to sell medicines via the internet. They must also ensure that there is an approved “White” list of such establishments. which can be accessed easily by the public.

It is the duty also of the Member State to ensure that it puts in place public information services so that the public are made aware of such services.

In addition, each pharmacy must have a website that contains on each page a "common" logo to show that the pharmacy is a legitimate and approved site from which to obtain medicines. The European Commission has to ensure that this logo is harmonised across the European Union and that it implements a common technology with electronic and cryptographic requirements for verification of the authenticity of the "common" logo.

There already exist national registers of pharmacies across Europe and around the world, and you can use this link to see if your country has one.

Is delivering medicines to the home fundamentally a good thing?

It shouldn't be forgotten that the ability of patients to receive medicines at home does confer many benefits, such as convenience to name but one. This is especially important for those living in remote places or who find it difficult to travel because of, for example, disability or immobility.  

However, the importance of ensuring that patients operate within the legal healthcare system and are not taken duped by criminals, makes it all the important to ensure that the public knows how to access genuine remote services in a scure environment.

 

 

 

 

 

 

 

 

News from ASOP EU

New scientific article aims to help simplify fake medicine terminology

4 Apr 2017

A new in depth analysis of the evolution of the descriptions applied to falsified, counterfeit and fake medicines has just been published. It aims to help clarify and simplify this hitherto controversial area. With the number of increasing illegally operating websites selling medicines across the world clear and easy to understand descriptors which will help to make public awareness raising campaigns more effective.

ASOP EU member adopts top level domain name .pharmacy

23 Mar 2017

To help ensure absolute security and recognition of a genuine fully legal online seller of medicines, the web page of the European Association of Mail Service Pharmacies (EAMSP) recently became the first in Europe to switch its Top Level Domain to .pharmacy. 

EAASM and ASOP EU to be present at the 22nd Congress of the European Association Of Hospital Pharmacists 22-24 March 2017.

10 Mar 2017

Mike Isles will be speaking on “Falsified Medicines: The Role of the Pharmacist in Raising Patient Awareness.

 

 

 

ASOP EU Members

 

Web design by Tribal Systems